高级检索
当前位置: 首页 > 详情页

Macular Atrophic versus Subretinal Proliferative Changes in Myopic and Age-Related Macular Degeneration: The 2-Continent Eye Study

文献详情

资源类型:
Pubmed体系:
机构: [1]Rothschild Foundation Hospital, Paris, France. [2]Singapore Eye Research Institute, Singapore National Eye Center, Singapore, Singapore. [3]Beijing Visual Science and Translational Eye Research Institute (BERI), Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing, China. [4]L V Prasad Eye Institute, Hyderabad, Telangana, India. [5]Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China. [6]New York Eye and Ear Infirmary of Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York. [7]Privatpraxis Prof Jonas und Dr. Panda-Jonas, Heidelberg, Germany. [8]Department of Ophthalmology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany. [9]Ufa Eye Research Institute, Bashkir State Medical University, Ufa, Russia. [10]Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing, China. [11]Suraj Eye Institute, Nagpur, India. [12]Department of Ophthalmology, University Hospital Heidelberg, Heidelberg, Germany.
出处:

关键词: Age-related macular degeneration Macula atrophy Pathologic myopia Subretinal fibrosis Subretinal proliferation

摘要:
To assess the prevalences of subfoveal retinal pigment epithelium (RPE) loss versus subfoveal tissue proliferation as causes of vision loss in patients with late-stage age-related macular degeneration (AMD) or myopic macular atrophy.Population-based studies conducted in Russia, China, and India and histological examination of enucleated human globes.The Russian Ural Eye and Medical Study (n = 5899 participants; age: ≥40 years), Ural Very Old Study (n = 1526; age: 85+ years), Beijing Eye Study (n = 3468; age: ≥40 years), and Central India Eye and Medical Study (n = 4711) were conducted in rural and urban regions in Bashkortostan/Russia, Beijing/China, and Nagpur/India, respectively. The histological study part included human eyes enucleated because of reasons like malignant melanomas, or were post mortem enucleated.The participants underwent a series of general medical and ophthalmological examinations including OCT of the macula. In the histological study part, the enucleated globes were histomorphometrically examined.Presence of RPE loss and of subretinal proliferations.In all 4 population-based studies combined, late-stage AMD and myopic macular atrophy were detected in 291 eyes and 46 eyes, respectively. Retinal pigment epithelium cell loss was dominant in 136 (94%) out of 145 eyes with geographic atrophy and in 35 (76%) out of 46 eyes with myopic macular atrophy, whereas subretinal proliferations were predominantly present in 127 (87%) out of 146 eyes with neovascular AMD. Among all 337 eyes with late AMD or myopic macular atrophy, RPE loss was the main cause for vision loss in 190 (56%) eyes and subretinal proliferations in 147 (44%) eyes, with no significant difference (P > 0.05) between the study cohorts. In the histological specimen, subretinal proliferations included melanin-bearing cells in contact with a periodic acid-Schiff-positive membrane, resembling RPE cells.Subretinal proliferations in the foveal region were the main reason for central visual acuity loss in 44% of all eyes with late AMD or myopic macular atrophy in 4 population-based studies. Subretinal foveal RPE cell proliferation and RPE loss are roughly equally important as a cause of vision loss in AMD and myopic macular atrophy.Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.© 2025 by the American Academy of Ophthalmologyé.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 3 区 医学
小类 | 2 区 眼科学
最新[2025]版:
大类 | 3 区 医学
小类 | 2 区 眼科学
第一作者:
第一作者机构: [1]Rothschild Foundation Hospital, Paris, France. [2]Singapore Eye Research Institute, Singapore National Eye Center, Singapore, Singapore. [3]Beijing Visual Science and Translational Eye Research Institute (BERI), Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing, China. [4]L V Prasad Eye Institute, Hyderabad, Telangana, India. [5]Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China. [6]New York Eye and Ear Infirmary of Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York. [7]Privatpraxis Prof Jonas und Dr. Panda-Jonas, Heidelberg, Germany.
共同第一作者:
通讯作者:
通讯机构: [3]Beijing Visual Science and Translational Eye Research Institute (BERI), Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing, China. [10]Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:28994 今日访问量:0 总访问量:1619 更新日期:2025-10-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)